The Technical Analyst
First Trust Amex Biotech [FBT]
Exchange: NYSE
First Trust Amex Biotech Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.85% $147.69
America/New_York / 8 mai 2024 @ 15:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3 079.34 mill |
| EPS: | 8.57 |
| P/E: | 17.22 |
| Earnings Date: | N/A |
| SharesOutstanding: | 20.85 mill |
| Avg Daily Volume: | 0.0256 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.72x |
| Company: PE 17.22 | sector: PE 23.85 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.27x |
| Company: PE 17.22 | industry: PE 13.52 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 145.49 - 149.89 ( +/- 1.49%) |
| ATR Model: 14 days |
Forecast:
16:00 - $147.69
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $147.69
Forecast 2: 16:00 - $147.69
Forecast 3: 16:00 - $147.69
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $147.69 (-0.85% ) |
| Volume | 0.0175 mill |
| Avg. Vol. | 0.0256 mill |
| % of Avg. Vol | 68.21 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For FBT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
FBT
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Latest News
2024-04-10 17:30:40 - Seeking Alpha
FBT: An Equal Weight Way To Play Biotech
Biotech stocks have not regained their 2021 peak levels, making them a potential catch-up trade. First Trust NYSE Arca Biotechnology Index Fund ETF is a fund that replicates the performance of the NYSE Arca Biotechnology Index. The FBT ETF invests equally in 30 leading biotech companies, offering exposure to the sector's growth potential with diversification.
2024-04-09 07:21:08 - Zacks Investment Research
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund launched on 06/19/2006.
2024-04-01 07:21:14 - Zacks Investment Research
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on 06/19/2006.
2024-02-05 07:21:13 - Zacks Investment Research
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
The First Trust NYSE Arca Biotechnology ETF (FBT) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
2024-01-30 07:21:19 - Zacks Investment Research
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on 06/19/2006.
2023-12-06 07:31:11 - Zacks Investment Research
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.
2023-11-27 07:31:15 - Zacks Investment Research
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
2023-09-27 07:31:09 - Zacks Investment Research
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Launched on 06/19/2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.
2023-09-26 07:31:22 - Zacks Investment Research
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on 06/19/2006.
2023-07-26 07:55:27 - Zacks Investment Research
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on 06/19/2006.